← Morphine

Patient counseling sheet

Print-ready and generated without storing patient details.

AfyaIndex · counseling handout

Morphine

Opioid analgesic

Prepared 05 Nov 2026

What it is used for

Prolonged relieve of severe and intractable pain acute or chronic; opioid adjunct during general anaesthesia; adjunct in acute pulmonary oedema; relief of severe dyspnoea. Clinical selection for Morphine should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Opioid analgesic. Confirm site-specific dose, duration and monitoring before prescribing.

Warnings

HIGH-ALERT. Monitor sedation/RR. Start low in elderly/renal/hepatic impairment. Constipation prophylaxis. Dependence/misuse risk. Avoid concurrent sedatives when possible (benzodiazepines — black box risk).

Possible side effects

Nausea and vomiting, dry mouth, anorexia, constipation, cramps, abdominal pain, lightheadedness, dizziness, sedation, sweating, facial flushing, arrhythmias, tachycardia, urinary retension or hesitancy, reduced libido, ureteral spasm, bronchospasm, muscle rigidity.

Storage

Store as labelled. Keep out of reach of children.

No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.

AfyaIndex dataset coverage